Open AccessProspective study of special stage II (T 2b-3 N 0 M 0 ) non-small-cell lung cancer treated with hypofractionated-simultaneous integrated boost-intensity modulated radiation therapy
Author(s) -
Wei Zhang,
Chengxin Liu,
Haiqun Lin,
Yipeng Song,
Wei Huang,
Hongsheng Li,
Miaomiao Li,
Baosheng Li
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.157332
Subject(s) - stage (stratigraphy) , lung cancer , intensity (physics) , medicine , nuclear medicine , oncology , cancer research , physics , biology , optics , paleontology
To analyze the effects of hypofractionated-simultaneous integrated boost-intensity modulated radiation therapy (Hypo-SIB-IMRT) on medically inoperable patients with special stage II (T2b-3N0M0) non-smallcell lung cancer (NSCLC).